Gsk (GSK) Market Capitalization (2026)

Gsk (GSK) has 18 years of Market Capitalization data on file, last reported at $107.7 billion in Q3 2026.

• For the quarter ending Q3 2026, Market Capitalization changed N/A year-over-year to $107.7 billion; the trailing twelve-month figure through Sep 2026 stood at $107.7 billion (changed N/A YoY), and the FY2025 full-year result was $105.8 billion, up 45.04% from the prior year.
• Market Capitalization was $107.7 billion for Q3 2026 at Gsk, down from $113.1 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $119.1 billion in Q1 2026 to a low of $63.4 billion in Q3 2022.
• A 5-year average of $88.4 billion and a median of $83.6 billion in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization decreased 22.95% in 2022 and surged 45.04% in 2025, its largest moves.
• Gsk's Market Capitalization stood at $75.8 billion in 2022, then rose by 5.48% to $79.9 billion in 2023, then dropped by 8.7% to $73.0 billion in 2024, then jumped by 45.04% to $105.8 billion in 2025, then increased by 1.75% to $107.7 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $107.7 billion in Q3 2026, $113.1 billion in Q2 2026, and $119.1 billion in Q1 2026.